Compare Neurocrine Biosciences Inc (NBIX) vs ProShares Ultra Gold ETF (UGL) Price & Performance

Neurocrine Biosciences IncTrade

ProShares Ultra Gold ETFTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs ProShares Ultra Gold ETF — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while ProShares Ultra Gold ETF trades at $44.96. The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, ProShares Ultra Gold ETF nearer its low. Which is the better fit depends on your goals.

	NBIX	UGL
Market Cap	$17.40B	—
Sector	Health	Leveraged / Inverse
52-Week High	$180.55	$85.62
52-Week Low	$123.10	$33.59
Enterprise Value	$16.49B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NBIX

Neurocrine Biosciences appoints Samir Siddhanti as Chief Business Officer to lead growth strategy.PRNewsWire · 5 hours agoBullish View details →

UGL

ProShares Ultra Gold and UltraShort Gold offer opposite 2x gold exposure but suit different tactical bets.24/7 Wall Street · 3 days agoNeutral Leveraged gold ETFs like UGL and GLL suffer significant decay in volatile markets, reducing expected returns.24/7 Wall Street · 4 days agoBearish View details →

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

About ProShares Ultra Gold ETF

UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.